dual agonist glp 1 glucagon GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes The mechanisms of dual incretin
Description
Most patients notice improved blood sugar control and changes in appetite within a few weeks
doi: 10.1007/s13300-018-0377-5
[DOI] [PubMed] [Google Scholar] 13.Hulst AH, Visscher MJ, Godfried MB, Thiel B, Gerritse BM, Scohy TV, et al
GLP-1 and glucagon co-agonists Glucagon is secreted from the pancreatic a-cells and the main physiological site of action is the liver to increase hepatic glucose production [60]
The discovery and development of liraglutide and semaglutide
